JAK Inhibitors vs. TNF Inhibitors: Understanding Infection Risks Despite concerns about treatment with immunosuppressive agents, coronavirus disease 2019 (COVID-19) infection remains low in patients with rheumatic diseases, according to 2 abstracts presented at the annual meeting of the American College of Rheumatology. With over 450 sessions, the meeting provides boundless opportunities for professional development, networking, and access to the latest rheumatology research and clinical applications. Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape. NeuroMetrix to Introduce Quell Fibromyalgia at the If you have questions about ACR Convergence or need help, visit the ACR Convergence support center to view our comprehensive frequently asked questions or connect with support staff. Contact: Tel: 41 44 716 30 30. During a session at the 2017 American College of Rheumatology Annual Meeting in San Diego, California, a cardiologist joined rheumatologists to give a detailed look at the relationship between rheumatic conditions and cardiovascular disease. Understanding the magnitude of infection risk with different therapies can help clinicians and their patients weigh the risks and benefits of different treatment regimens in shared decision making. They also urge moving away from prednisone. This year has been an exciting time for rheumatologists with impressive clinical trial results and promising outcomes for patients, said Susan Manzi, MD, MPH, codirector of the Lupus Center of Excellence and chair of the Department of Medicine of West Penn Allegheny Health System, during a session at the American College of Rheumatology annual meeting in Atlanta, Georgia. Opportunistic infections were rare, with an incidence rate of 0.11 for JAK inhibitor-treated patients and 0.49 for TNF inhibitor-treated patients. Physician business owners discuss direct care models and their future in rheumatology, Social media can facilitate connections and collaboration to advance rheumatology, Panel outlines ACR Workforce Solutions Committee initiatives, Proposed classification criteria for pediatric CNO and CRMO explained, Experts share best practices and recent insights to improve care for Sjgrens syndrome, ACR advocacy outlines legislative priorities, how members can get involved, Trans-omic technologies bring new insights into immune-mediated disease pathology, Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era, Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment, Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block, Sabine Sparre Dieperink, MD: The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry, Beyond the Joints: Take a Deeper Look at Gout, Herpes Zoster and Immunocompromised Individuals, Communicating to Patients with Osteoporosis, Living with EGPA: Disease and Oral Corticosteroid Burden. ChemoCentryx Announces Presentations at the 2022 American Cumulative childhood stressis a risk factor for autoimmune disease, No Route Map: The Complex Healthcare Journeys of People with Fibromyalgia a Record Linkage Study in the UK, Finally, I Can Do Something About It Myself: A Process Evaluation of the Plants for Joints Lifestyle Intervention, The Best Part Is Feeling Like I Could Go out There and Maybe Really Help Somebody: Training Peer Coaches to Deliver the Moving Well Total Knee Replacement Telephone-Based Coaching Program, [68Ga]- CPCR4 Trifluoroacetate PET/CT Imaging of Chemokine Receptor CXCR4- Expression in Systemic Sclerosis Related Interstitial Lung Disease, 12-month Findings of the Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR RCT), 18F-FDG PET-MR Characterization of Aortitis in the IL1rn-/- Mouse Model of Giant-Cell Arteritis, 2022 Revision of the ACR/EULAR Remission Criteria for Rheumatoid Arthritis, 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) Data from the RELIANCE Registry, A 48-week Analysis of a Pan-EU Real-world Study of SB5 Biosimilar Following Transition from Reference Adalimumab in Patients with Rheumatoid Arthritis, Axial Spondyloarthritis or Psoriatic Arthritis, A Clinical Study Designed to Support a Demonstration of Interchangeability Between AVT02 and Reference Adalimumab (Humira), A Cluster of Paget Disease of the Bone in Black or African American Patients in a Veteran Population, A Comparitive Study of NLRP3- and NLRP12-autoinflammatory Disease, A Core Inflammation Program Conserved Across Human and Murine Neutrophils, A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis). The majority of opportunistic infections were tuberculosis, with an incidence rate of 0.12 for JAK inhibitor-treated patients and 0.49 for TNF inhibitor-treated patients. If you log out, you will be required to enter your username and password the next time you visit. Copyright 20062023 American College of Rheumatology. Although patient-reported outcomes (PROs) are increasingly being used to understand treatment effectiveness, there is still a lot unknown about what measures patients find most important. November 13th 2019. Learn more about the ACR Centennial and be sure to add the Centennial Gala to your registration. November10-14,2022; Philadelphia, Pennsylvania. 2023 American College of Rheumatology. This study found that patients with RA who initiated treatment with JAK inhibitors had a very high incidence of herpes zoster, with almost double the risk of patients who initiated treatment with TNF inhibitors. Filed Under: ACR Convergence, DMARDs & Immunosuppressives, Drug Updates Tagged With: ACR Convergence 2022, Infection, JAK inhibitors, Janus Kinase Inhibitors, Rheumatoid Arthritis (RA), TNF inhibitors, tumor necrosis factor (TNF) inhibitors. Your registration will not be complete until you provide this verification. Two abstracts presented at the American College of Rheumatologys annual meeting evaluated PROs in rheumatology and how PRO measures can be used in clinical care. The incidence rate per 100 person-years for herpes zoster was 11.54 for JAK inhibitor-treated patients and 4.88 for TNF inhibitor-treated patients. On-demand access to scientific sessions, Community Hub sessions, industry sessions, posters, and exhibitor profiles is now available on our new virtual meeting website. The mean follow-up was 1.16 years, with the most frequent infection being herpes zoster. Clinical Congress offers outstanding educational opportunities for every stage in your careerall in one place. Sharon L. Kolasinski, MD, FACR. All rights reserved. First Classification Criteria Proposed for Chronic Osteomyelitis, Retention High With Biosimilar-to-Biosimilar Switch for Arthritis, Lower HCQ Dose for Lupus Tied to Hospitalizations for Flares, Rheumatology Workforce Shortage Demands Multipronged Approach, Ask Knee OA Patients About Stair Climbing Difficulty, ACR, EULAR Roll Out Updated Antiphospholipid Syndrome Criteria, Sarilumab Effective for Polymyalgia Rheumatica in Phase 3 Trial, Intensive Gout Treatment Meets Urate Goal, Lowers Tophi Burden, Denosumab May Halt Erosive Hand Osteoarthritis Progression, Knee OA Pain Eased in Community-Based Weight-Loss Programs, HCQ Doesn't Prevent or Delay Onset of Rheumatoid Arthritis, Opioids Increase Risk for All-Cause Deaths in RA vs. NSAIDs, Combination Therapy May Boost Remission in JIA, Combo Therapy Shows Mixed Results for SSc-Related Lung Disease, Prednisone, Colchicine Equally Efficacious for CPP Arthritis, NSAIDs for Spondyloarthritis May Affect Time to Conception, Remibrutinib Safe for Sjgren's in Phase 2, CTD-ILD: Rituximab 'a Reasonable Alternative to Cyclophosphamide', First Recommendations for Cancer Screening in Myositis Issued, Clinical Signs Differ Between Kids and Adults With Vasculitis, Psoriatic Arthritis Highlights From ACR 2022, Vitamin D and Omega-3 Supplements Reduce Autoimmune Disease Risk, Tofacitinib Postmarketing Data Shed Light on JAK Inhibitor Risks, Low-Dose Rituximab May Keep RA Activity Low in Responders. The PSS-weighted HR [95% Cl] for individual infection types comparing patients taking JAK inhibitors with those taking TNF inhibitors was: 1) herpes zoster: 2.37 [95% Cl, 2.002.80]; 2) serious bacterial infections: 1.04 [95% CI, 0.711.52]; and 3) opportunistic infections: 0.25 [0.090.73]. ACR Convergence 2020 Archives - ACR Meeting Abstracts The 27 individuals recognized in 2022 as ACR Masters . Clinical Congress 2022. Netherlands found. Yongdong Dan Zhao, MD, PhD, RhMSUS, explained how point values are assigned for each of the 10 criteria. Medscape Rheumatology, February 10, 2022. When a JAK Inhibitor Fails for a Patient With RA, What's Next? Questions? 2018 ACR/ARHP Abstract Supplement (PDF) - 33mb. If not verified, you will not be able to attend the meeting. Meital Yerushalmi on LinkedIn: I had a great experience attending the In Debate Over Biosimilar Switching, Cost Is Key, Among the most anticipated sessions at the 2017 meeting of the American College of Rheumatology in San Diego, California was The Great Debate: Biosimilarsto Switch, or Not to Switch? Longer-term HCQ-induced retinopathy risk must be balanced with shorter-term risk for hospitalization for an SLE flare from a lower dose, researchers say. ACR Convergence Registration and Hotel Support Center. Cancellations are not accepted and refunds will not be issued. Download a Manual Credit Tracker to help. Register for ACR Convergence 2022 - Convention Management Resources, Inc. Home - ACR Convergence Today Download Abstracts. ACR/ARHP Annual Meeting Research Abstract Submission Tips November 14, 2022. We look forward to seeing you this fall! Click on an entry to view abstracts for that meeting. Thieves Market is an interactive session where fascinating clinical cases relevant to rheumatology are presented in short presentations. Check back for more from the ACR Convergence 2021. Learn about new, pilot ACR/ARP membership offerings coming soon. Jean Liew, MD, MS, shared her expertise with social media and how the COVID-19 Global Rheumatology Alliance used it to benefit the field. Evaluating Sarilumab's Efficacy as a Monotherapy in Rheumatoid Arthritis. Patients With Rheumatic Diseases at No Greater Risk of Contracting COVID-19. How are we doing? ISSN 1931-3268 (print) Using Patient Characteristics to Predict Clinical Outcomes in RA. The Many Benefits of, and Barriers to, Exercise in Patients With Rheumatologic Diseases. Fraenkel L, Bathon JM, England BR, et al. That Is the Question., Dr Grace C. Wright Explains How Vectra DA Helps Choose Treatments in RA. If you log out, you will be required to enter your username and password the next time you visit. Federal Agencies Address the Dual Crises of Pain and Opioid Addiction. Powered By TriStar Event Media, LLC. Nominate an exceptional colleague for an award today. Treat-To-Target Approach Beneficial for Rheumatoid Arthritis Treatment. ora-2022-annual-scientific-meeting June 1-4, 2022 - EULAR 2022: European Congress of Rheuma-tology, Copenhagen, Denmark. American College of Rheumatology Annual Meeting - Healio Abstracts are available for the meetings listed below. All ACR meetings and educational activities are subject to the ACR Code of Conduct. The American College of Rheumatology's Annual Meeting is your gateway to global rheumatology education. Join a community that aims to help you excel in your specialty. Give us your feedback on the new rheumatology.org. Upon receipt of your request and proof of status, CMR will send you an invitation code to input during the online registration process to receive the discounted registration fee. Methods: This cohort study used the Korea National Health Insurance Service database of patients with RA, examining patients who initiated treatment with a JAK inhibitor or TNF inhibitor between 2009 and 2019. Elevate the social media conversation surrounding ACR Convergence. You will be directed to the rheumatology.org. The Rheumatology Research Foundation is the largest private funding source for rheumatology research and training in the United States. 49E CONGRES ANNUEL - SIMS 2023. Gather your team for the ACR Knowledge Bowl. The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. knee or hip replacement surgery than those who take direct oral anticoagulants. The title "Reshaping the Relationship Between Physicians and PBMs" suggested that the Sunday session at the 2017 American College of Rheumatologys Annual Meeting in San Diego, California, would focus on reconciling the goals of providers and pharmacy benefit managers (PBMs), but physicians challenges in dealing with PBMs quickly became the primary focus of the panel discussion. Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape. The 2023 ACR Annual Meeting will take place at the Washington Hilton, May 6-10. November 10-14, 2022 - American College of Rheumatology (ACR) Convergence 2022, Philadelphia, Pennsylvania, USA. ISSN 1931-3209 (online), Systemic Lupus Erythematosus Resource Center, Researchers Give Update on Janus Kinase (JAK) Inhibitors, FDA Requires New Boxed Warnings on JAK Inhibitors, Places Restrictions on Use, Small Increased Risk for CIN & Cervical CA with TNF Inhibitors, Effects of Warfarin on Risk of Hip & Knee Replacement in OA Patients, 2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis, Risk of infections between JAK inhibitors and TNF inhibitors among patients with rheumatoid arthritis. Indications for Total Hip and Knee Replacement, Reproductive Health in Rheumatic Diseases, Pediatric to Adult Rheumatology Care Transition, See Education Exchange details & register. Headquartered in Atlanta, GA, this medical society serves over 7,700 physicians, health professionals, and scientists worldwide who work in the medical subspecialty of rheumatology. Submit your best science for peer review and a chance to be published in a special online supplement of Arthritis & Rheumatology. HSS Presents New Research at the ACR Convergence 2022 We use cookies on our website to improve our service to you and for security purposes. Register now for the ACRs premier spring event, comprising six meetings taking place in one location, April 2830, in Orlando, Florida. In a Tuesday panel discussion at The American College of Rheumatologys 2017 Annual Meeting in San Diego, California, representatives from HHS, the National Institutes of Health (NIH), and the CDC outlined ongoing federal initiatives to address the parallel problems of pain and opioid addiction. ACR Convergence, the ACR's annual meeting is the world's premier rheumatology experience. WOBURN, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) will introduce Quell Fibromyalgia at the American College of Rheumatology Annual Meeting, ACR Convergence 2022, on . Give us your feedback on the new rheumatology.org. Additionally, the ACR and the Association of Rheumatology Professionals (ARP) honored two rheumatologists and a social worker with distinguished awards. The summit will include two sessions built by learners participation. ACR Convergence 2021 again will bring the best in rheumatology education and networking together in one place. European Alliance of Associations for Rheumatology Congress - EULAR 2023. Medflixs - ACR American College of Rheumatology 2022 Dr Stephen Messier Discusses the Importance of Nonpharmacologic Interventions in Knee OA. A Clinical Study Designed to Support a Demonstration of Interchangeability Between AVT02 and Reference Adalimumab (Humira) Abstract Number: 1316 A Cluster of Paget Disease of the Bone in Black or African American Patients in a Veteran Population Abstract Number: 1853 A Comparitive Study of NLRP3- and NLRP12-autoinflammatory Disease ACR Convergence 2022 attendees should have received instructions via email on how to log in to the new website and access content. Nondrug therapies that might have been dismissed 30 years ago are now the sorts of treatments physicians are turning to instead of overused treatments like surgical procedures, opioids, and injections, said Daniel Clauw, MD, professor of anesthesiology, medicine (rheumatology), and psychiatry; director of translational research; and director of the Center for Chronic Pain and Fatigue Research. Find a rheumatology provider. American College of Rheumatology Annual Meeting - AJMC Patients with rheumatoid arthritis (RA) not only deal with functional impairment, but also pain, fatigue, and other symptoms driven by interleukin (IL)-6 levels. in a comparison of adults 65 years or older with rheumatoid arthritis. American Society of Clinical Oncology (ASCO) Congress from 2nd - 6th of June 2023, Chicago, USA 1 min Evolving Patient Journeys in Food Allergy Friday, 9 June 2023: 12:00-13:00 CEST Live symposium at EAACI 2023, register at EAACI and sign-up for exclusive content from the symposium shortly after. Only Convention Management Resources (CMR) - the official registration agent for ACR Convergence - is authorized to confirm your registration. Dr Jeffrey Curtis Discusses Using Live Virus Vaccines in Immunocompromised Patients. Medscape RheumatologyWebMD, LLC Using Technology and Virtual Reality to Improve Outcomes, Quality of Life. GAC Chair Blair Solow, MD, MSc, explained the committees current priorities. Indications for Total Hip and Knee Replacement, Reproductive Health in Rheumatic Diseases, Pediatric to Adult Rheumatology Care Transition. Jean Liew, MD, MS, shared her expertise with social media and how the COVID-19 Global Rheumatology Alliance used it to benefit the field. Date : 2023-06-16 ; 4392 0 . Give us your feedback on the new rheumatology.org. ACR Convergence 2023, the worlds premier rheumatology experience, will be held November 1015 at the San Diego Convention Center in San Diego, California. This website also contains material copyrighted by 3rd parties. Medscape RheumatologyWebMD, LLC The attendee's email address is required above. On-demand access to scientific sessions, Community Hub sessions, industry sessions, posters, and exhibitor profiles is now available on our new virtual meeting website. MACRA Challenges Lead to New ACR Alternative Payment Model. Can I still claim CME/MOC?Virtual and in-person attendees can still claim CME credit/MOC points on the My Credit page; however, you are responsible for keeping track of your credit. Date : 2023-05-31 ; 1811 . Submit your most unique and thought-provoking case. ACR/ARP members receive discounted registration fees, access to publications, unparalleled resources, and more. However, its important to understand which agents have a higher propensity for infection because these treatments provide remarkable results for controlling RA, limiting long-term disability and improving patient quality of life. Dr. Monotherapy was a big topic of conversation at the American College of Rheumatologys annual meeting, held November 8-13 in Atlanta, Georgia, and 2 abstracts highlight the efficacy of sarilumab as a monotherapy in patients with rheumatoid arthritis. New technologies that can monitor sleep, track itching patterns, or assist with pain are improving outcomes and quality of life for patients with rheumatologic conditions, according to panelists at the American College of Rheumatologys annual meeting. However, exercise needs to be modified for these patients to address the unique barriers they may have compared with the general population, said panelists during a session at the American College of Rheumatologys annual meeting. What's New in Sjgren Disease: Update From ACR 2021. PDF Annual Meeting Schedule at a Glance - American College of Rheumatology Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital. Virtual Platform Registration. Grouping patients into clusters based on shared characteristics, such as disease control and general health, may be helpful in understanding and predicting clinical outcomes in patients with rheumatoid arthritis (RA), according to an abstract presented at the 2019 ACR/ARP Annual Meeting, held November 8-13 in Atlanta, Georgia. Questions? Join a community that aims to help you excel in your specialty. ACR Convergence 2023, the worlds premier rheumatology experience, will be held November 1015 at the San Diego Convention Center in San Diego, California.